Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMICTAL extended-release adjunctive therapy in partial seizures
2004-004342-41Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in epilepsy, sponsored by GSK. Started Jan 2005; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2004-004342-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004342-41.